Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
By:
References
- 1. Ganev T, Petkova L, Statelov T, Stamboliyski V, Hinev A, Evtimov N. Clinical experience in the treatment of invasive bladder cancer. Uronet. 2011;3:29-34.
- 2. Evtimov N, Ganev T, Stamboliyski V. Complications in the choice of laparoscopic surgical technique. Urology. 2015:2;36-41.
- 3. Arends TJ, Nativ O, Maffezzini M. et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol. 2016 Jun;69(6):1046-52.10.1016/j.eururo.2016.01.00626803476
- 4. Chou R, Selph S, Buckley DI. et al. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. J Urol. 2017 May;197(5):1189-99.10.1016/j.juro.2016.12.09028027868
- 5. Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer - a current perspective. Nat Rev Urol. 2014 Mar;11(3):153-62.10.1038/nrurol.2014.1524492433
- 6. Porten SP, Leapman MS, Greene KL. Intravesical chemotherapy in non-muscle-invasive bladder cancer. Indian J Urol. 2015 Oct-Dec;31(4): 297-303.10.4103/0970-1591.166446462691326604440
DOI: https://doi.org/10.2478/jbcr-2022-0009 | Journal eISSN: 1313-9053
Language: English
Page range: 70 - 73
Submitted on: Jan 18, 2022
Accepted on: May 11, 2022
Published on: Jul 13, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2022 Nikolay I. Nikolov, Vladislav R. Dunev, Angel A. Anatoliev, Nikolay H. Kolev, Martin B. Stoykov, Boyan S. Atanasov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.